Know Cancer

or
forgot password

A Pilot Study Using the Gynecologic Cancer Lymphedema Questionnaire as a Clinical Care Tool to Identify Lower Extremity Lymphedema


N/A
21 Years
N/A
Not Enrolling
Female
Ovarian Cancer, Uterine Cancer, Vaginal Cancer, Lymphedema

Thank you

Trial Information

A Pilot Study Using the Gynecologic Cancer Lymphedema Questionnaire as a Clinical Care Tool to Identify Lower Extremity Lymphedema


Inclusion Criteria:



- Study group of Gynecologic cancer survivors with Lymphedema

- Documented lower extremity lymphedema

- History of a primary diagnosis of gynecologic cancer (vulvar, cervical and uterine
only)

- History of surgery for gynecologic cancer including lymph node removal

- No evidence of disease or active treatment

- At least 21 years of age

- Able and willing to provide informed consent

- English fluency Comparison Group of Gynecologic Cancer Survivors without Lymphedema

- No history of lower extremity lymphedema or presence of lymphedema confirmed by limb
volume measurements at the time of study participation

- History of a primary diagnosis of gynecologic cancer (vulvar, cervical and uterine
only)

- History of surgery for gynecologic cancer including lymph node removal

- No evidence of disease or active treatment

- At least 21 years of age

- Able and willing to provide informed consent

- English fluency

Exclusion Criteria:

- Inability to participate in an informed consent process

- Patients with a psychiatric disorder precluding response to the survey

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

To determine if the Gynecologic Cancer Lymphedema Questionnaire (GCLQ)tools detects lower extremity lymphedema symptoms in gynecologic cancer survivors & if it is a feasible assessment tool which can be used in the clinical care setting.

Outcome Time Frame:

2 years

Safety Issue:

No

Principal Investigator

Richard Barakat, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Memorial Sloan-Kettering Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

09-077

NCT ID:

NCT00944944

Start Date:

July 2009

Completion Date:

January 2010

Related Keywords:

  • Ovarian Cancer
  • Uterine Cancer
  • Vaginal Cancer
  • Lymphedema
  • CORPUS UTERI,
  • ENDOMETRIUM
  • FALLOPIAN TUBE
  • OVARY
  • VAGINA
  • Lymphedema
  • Questionnaire
  • Quality of Life
  • 09-077
  • Fallopian Tubes
  • Lymphedema
  • Ovarian Neoplasms
  • Uterine Neoplasms
  • Vaginal Neoplasms

Name

Location

Memorial Sloan Kettering Cancer CenterNew York, New York  10021